Intraoperative detection and resection of occult neuroblastoma: A technique exploiting somatostatin receptor expression☆,☆☆
References (53)
- et al.
Isolation of a stem cell for neurons and glia from the mammalian neural crest
Cell
(1992) - et al.
The cholinergic neuronal differentiation factor from heart cell conditioned medium is different from the cholinergic factors in sciatic nerve and spinal cord
Dev Biol
(1990) - et al.
Acquisition of cholinergic and peptidergic properties by sympathetic innervation of rat sweat glands requires interaction with normal target
Neuron
(1990) - et al.
Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children
J Pediatr
(1993) - et al.
The role of multimodal therapy in patients with local and regional neuroblastoma
J Pediatr Surg
(1984) - et al.
Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma
J Pediatr Surg
(1991) - et al.
Improvement in survival after excision of primary tumor in stage III neuroblastoma
J Pediatr Surg
(1989) - et al.
Therapeutic significance of surgery in advanced neuroblastoma: A report from the study group of Japan
J Pediatr Surg
(1992) - et al.
Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analogue
J Pediatr
(1987) - et al.
Linear growth during long-term treatment with somatostatin analog (SMS 201–995) for persistent hyperinsulinemic hypoglyemia of infancy
J Pediatr
(1990)
Mechanism of action of long-acting analogs of somatostatin
Regul Pept
(1993)
Novel selective radioligand for one population of rat cortexsomatostain receptors
Life Sci
(1985)
Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC
J Pharmacol Method
(1985)
LIGAND: A versatile computerized approach for the characterization of ligand binding systems
Anal Biochem
(1980)
The role of surgery in localized neuroblastoma
J Pediatr Surg
(1985)
An evaluation of the role of surgery in metastatic neuroblastoma
J Pediatr Surg
(1988)
An evaluation of the role of surgery in disseminated neuroblastoma: A report from the Children's Cancer Study Group
J Pediatr Surg
(1983)
Resection of the primary tumor is appropriate for children with stage IV-S neuroblastoma: An analysis of 37 patients
J Pediatr Surg
(1992)
Surgical management and outcome of locoregional neuroblastoma: Comparison of the Childrens Cancer Group and the International Staging Systems
J Pediatr Surg
(1995)
Improved survival rates in children over 1 year of age with stage III or IV neuroblastoma following an intensive chemotherapeutic regimen
J Pediatr Surg
(1989)
Stage 4 neuroblastoma diagnosed at more than 1 year of age: Gross total resection and clinical outcome
J Pediatr Surg
(1994)
Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation of preparatory “debulking” treatments
J Pediatr Surg
(1992)
Neuroblastoma: Correlation of tumor neuropeptide contents with known prognostic factors
Cancer
(1992)
Characterization of somatostatin receptors on human neuroblastoma tumors
Cell Growth Differentiation
(1994)
Identification, characterization, and biological activity of somatostatin receptors in human neuroblastoma cell lines
Cancer Res
(1994)
Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors
Cancer Res
(1989)
Cited by (20)
Radioguided surgery in neuroendocrine tumors. A review of the literature
2014, Revista Espanola de Medicina Nuclear e Imagen MolecularAggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant
2005, Journal of Pediatric SurgerySomatostatin receptor gene expression in neuroblastoma
2000, Regulatory PeptidesAbove and Beyond Robotic Surgery and 3D Modelling in Paediatric Cancer Surgery
2021, Frontiers in PediatricsApplication of nuclear medicine to achieve less invasive surgery for malignant solid tumors in children
2014, Pediatrics International
- ☆
Presented in part at the 46th Annual Symposium of the Society of Surgical Oncology, Los Angeles, California, March 20, 1993.
- ☆☆
Supported by grants from NCI RO1CA41997 (MSO), Children's Hospital Research Foundation (MSO), NIH MO1 RR00034 (TMO), and Ohio Edison Biotechnology (MSO). Deborah A. Martinez was supported by an ACS Fellowship.
Copyright © 1995 Published by Elsevier Inc.